SENSEX NIFTY
You are here : Moneycontrol > Markets > Share/Stock Price > Pharmaceuticals > GlaxoSmithKline Pharmaceuticals

GlaxoSmithKline Pharmaceuticals

BSE: 500660 | NSE: GLAXO | ISIN: INE159A01016 | SECTOR: PHARMACEUTICALS
OR
Add to Watchist
Have you invested in these stocks? You can track them better in your Portfolio
LIVE
BSE
Feb 05, 16:01
3290.80
76.60 (+2.38%)
VOLUME 1,328
AVERAGE VOLUME
5-Day 1,020
10-Day 1,183
30-Day 1,142
VOLUME SHOCKER
5-Day 1,020
10-Day 1,183
30-Day 1,142
Prev. Close
3214.20
Open Price
3226.00
Bid PRICE (QTY.)
3290.80 (14)
Offer PRICE (Qty.)
3317.00 (1)
VWAP 3269.93
Market
Depth

Market Depth (07 Feb 2016)

BUY SELL
QTY PRICE PRICE QTY
5 3290.00 3310.00 16
7 3285.00 3317.00 6
5 3275.55 3317.95 5
1 3250.00 3324.00 1
1 3245.05 3325.00 5
224 Total 117 Total

Buy Qty

224

Sell QTY

117

Today's Low/High 3226.00 3310.00
52 Wk Low/High 2965.65 3825.00
L/U Price Band 2,571.40 3,857.00
LIVE
NSE
Feb 05, 16:01
3306.30
79.50 (+2.46%)
VOLUME 8,560
AVERAGE VOLUME
5-Day 8,985
10-Day 7,839
30-Day 9,223
VOLUME SHOCKER
5-Day 8,985
10-Day 7,839
30-Day 9,223
Prev. Close
3226.80
Open Price
3226.00
Bid PRICE (QTY.)
3306.30 (14)
Offer PRICE (Qty.)
0.00 (0)
VWAP 3257.11
Today's Low/High 3215.00 3348.80
52 Wk Low/High 2961.00 3825.00
L/U Price Band 2,581.45 3,872.15
Action in GlaxoSmithKline Pharmaceuticals

No recommendations so far.

What's your call on GlaxoSmithKline today?
Read 2 investor views

Consolidated
MARKET CAP (Rs Cr)
27,874.07
P/E
82.60
BOOK VALUE (Rs)
218.61
DIV (%)
625.00%
Market Lot
1
INDUSTRY P/E
33.10
EPS (TTM)
39.84
P/C
76.82
PRICE/BOOK
15.05
DIV YIELD.(%)
1.90%
FACE VALUE (Rs)
10.00
DELIVERABLES (%)
78.97 new
DELIVERY AVERAGES
3-Day 74.19%
5-Day 74.86%
8-Day 69.95%
* Note - Trailing EPS is displayed only when latest 4 quarter results are available.
Track GlaxoSmithKline on the go with moneycontrol app
UPCOMING CORPORATE ACTION
Board Meeting
on 10-Feb-2016 (Quarterly Results)
EXPAND ALL COLLAPSE ALL

Top Trading Ideas

2 February 2016

sell

BharatForge Feb Fut

Entry Price (Rs)

823.00

Exit Price (Rs)

813.00

Gain (Rs)

10.00

sell

Century Feb Fut

Entry Price (Rs)

515.00

Exit Price (Rs)

508.00

Gain (Rs)

7.00

sell

HPCL Feb Fut

Entry Price (Rs)

785.50

Exit Price (Rs)

778.00

Gain (Rs)

8.00

sell

SunPharma Feb Fut

Entry Price (Rs)

876.00

Exit Price (Rs)

868.30

Gain (Rs)

8.00

buy

NIFTY Feb Fut

Entry Price (Rs)

7,515.00

Exit Price (Rs)

7,571.00

Gain (Rs)

56.00

buy

DaburIndia Feb Fut

Entry Price (Rs)

249.00

Exit Price (Rs)

252.15

Gain (Rs)

3.00

Historic Prices & Simple Moving Averages
on
1 week  |  1 month  |  3 month  |  1 year  |  2 year
  1 Year Current %Gain / Loss
Open Price 3372.05 3226.00  
High Price 3388.00 3310.00  
Low Price 3285.00 3226.00  
Last Price 3301.55 3290.80 -0.33
Volume 1,088 1,328 22.06
Simple Moving Averages
Days BSE NSE
30 3235.40 3243.37
50 3250.84 3259.47
150 3331.03 3338.87
200 3300.78 3308.17

Get Historical Stock Prices »

Click here to view the Open, High, Low, Close, Volume and Spread data for GlaxoSmithKline

News/Videos & Announcements
Stock Advice & Research Reports
News Across the Web
Financials
Income Statement
 Standalone Sep'15 Jun'15 Mar'15
Dec'14
Net Sales 691.90 621.85 613.47 646.15
Other Income 31.34 39.88 40.48 37.77
PBDIT 128.87 110.01 125.77 114.67
Net Profit 96.05 93.28 102.85 45.30

Annual Report

Download in PDF format 2015 |2011 |2010
Balance Sheet
Mar'15
(In Rs Cr)
Total Share Capital 84.70
Net Worth 1,851.67
Total Debt 2.63
Net Block 123.06
Investments 47.67
Total Assets 1,854.30
Peers
Peer Comparison
Company Name Last Price %
Change
52 wk
High
52 wk
Low
Market Cap
Sun Pharma 856.80 2.91 1200.70 706.40 206,203.15
Lupin 1801.45 9.04 2127.00 1570.45 81,161.36
Dr Reddys Labs 3109.05 3.38 4382.95 2750.00 53,042.77
Cipla 569.95 3.58 752.45 540.55 45,785.34
Aurobindo Pharm 762.55 2.94 891.50 490.50 44,595.41
More » 
Share Holding Pattern & Mutual Funds Holding
Share Holding Pattern in (%)
 Sep' 15Jun' 15Mar' 15Dec' 14
Promoter75.0075.0075.0075.00
FII2.212.092.142.06
DII9.389.269.369.55
Others13.4113.6513.5013.39
Total100.00100.00100.00100.00
Company Information
REGISTERED OFFICE
Address
Dr. Annie Besant Road ,
City
Mumbai
State
Maharashtra
Pin Code
400030
Tel. No.
022-24959595
Fax No.
022-24959494
Email:
REGISTRARS
Name
Karvy Computershare Private Ltd.
Address
Karvy Selenium Tower B Plot no. 31-32, Gachibowli Financial District Nanakramguda
City
Hyderabad - 500032
State
Telangana
Tel. No.
040-23001153
Fax No.
Email:
Internet
MANAGEMENT
Name
Designation
D S Parekh
Chairman
H B Joshipura
Managing Director
A Aristidou
Director
R R Bajaaj
Director
A Bansal
Director
Message Board & Community
Right Time + Right Stock + Right Investment = HIGH PROFIT

APL Apollo Tubes Recommended on Oct 12th 2015

Recommended price 538.00  |  Peak from reco 839.50 56.16%

For more multi bagger recommendations click here

What are Multi baggers?

Our experts panel will help you to get you those life-changing stocks, tomorrow's bluechips today.

About GlaxoSmithKline

GlaxoSmithKline is in the Pharmaceuticals sector. The current market capitalisation stands at Rs 27,874.07 crore.

The company management includes D S Parekh - Chairman, H B Joshipura - Managing Director, A Aristidou - Director, R R Bajaaj - Director, A Bansal - Director, P V Bhide - Director, N Kaviratne - Director, R Krishnaswamy - Director, A N Roy - Director, R C Sequeira - Director, D Sundaram - Director, Regis Simard - Non Executive Director.

It is listed on the BSE with a BSE Code of 500660 and the NSE with an NSE Code of GLAXO.

Its Registered office is at Dr. Annie Besant Road , Mumbai,Maharashtra - 400030.

Their Registrars are Karvy Computershare Private Ltd.

Quick Links for GlaxoSmithKline Pharmaceuticals
Explore Moneycontrol
Stocks     A | B | C | D | E | F | G | H | I | J | K | L | M | N | O | P | Q | R | S | T | U | V | W | X | Y | Z | Others
Mutual Funds     A | B | C | D | E | F | G | H | I | J | K | L | M | N | O | P | Q | R | S | T | U | V | W | X | Y | Z
Copyright © e-Eighteen.com Ltd. All rights reserved. Reproduction of news articles, photos, videos or any other content in whole or in part in any form or medium without express written permission of moneycontrol.com is prohibited.
Results of GlaxoSmithKline